BiocSol's Timeline
2012
BCA collection gathering
Assembly and identification of a collection of promising biocontrol agents within the plant health and microbiology labs of UCLouvain.
2015-2018
Screening Preliminary trials
Evaluation and screening of the most promising agents via direct confrontation tests.
2019
Spin-off Incubation
Creation and incubation of Biocsol through the “Win4SpinOff” program supported by Wallonia.
2020
Formulation Indoor & field POC
Development of prototype formulations, followed by the first integrated “in planta” trial program
2021
First industrial production
Pilot production in preparation for the first large-scale trial program in multiple countries.
2023
Spin-off Incorporation 3 patent sub.
Formal establishment of BiocSol as a legal entity and patent submission in preparation of the seed round capital raise.
2024
Seedround 10M€
BiocSol secures 10M€ seed funding via multiple investors to kickstart its operations and accelerate the development of its products.
2025
Start regulatory process
BiocSol’s team is expanding, and with this growth, the company is beginning the process of registering its first product in Europe.